Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | USP2 | O75604 | 2/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.47 |
| ▸ | FAAH | O00519 | 2/20 | 0.45 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11741042 | 1.00 | TSHR (0.67) | TSHRALDH1A1USP2FFAR4FFAR1 | |
| SCHEMBL11698081 | 1.00 | TSHR (0.67) | TSHRALDH1A1USP2FFAR4FFAR1 | |
| SCHEMBL9542809 | 1.00 | TSHR (0.67) | TSHRALDH1A1USP2FFAR4FFAR1 | |
| SCHEMBL13219935 | 1.00 | TSHR (0.67) | TSHRALDH1A1USP2FFAR4FFAR1 | |
| SCHEMBL19721792 | 1.00 | TSHR (0.67) | TSHRALDH1A1USP2FFAR4FFAR1 | |
| SCHEMBL9541562 | 1.00 | TSHR (0.67) | TSHRALDH1A1USP2FFAR4FFAR1 | |
| SCHEMBL15635268 | 1.00 | TSHR (0.67) | TSHRALDH1A1USP2FFAR4FFAR1 | |
| SCHEMBL3032108 | 1.00 | TSHR (0.67) | TSHRALDH1A1USP2FFAR4FFAR1 | |
| SCHEMBL20500832 | 1.00 | TSHR (0.67) | TSHRALDH1A1USP2FFAR4FFAR1 | |
| SCHEMBL9015418 | 1.00 | TSHR (0.67) | TSHRALDH1A1USP2FFAR4FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2773680-A1 | PLASTICIZERS FOR ADHESIVE, COATING AND SEALANT COMPOSITIONS APPLIED TO ASPHALT | Henry Company LLC (US) | 2014-09-10 | — | — | EP | claimed |
| WO-2013067062-A1 | PLASTICIZERS FOR ADHESIVE, COATING AND SEALANT COMPOSITIONS APPLIED TO ASPHALT | HENRY COMPANY LLC (US) | 2013-05-10 | — | — | WO | claimed |
| US-20250332112-A1 | IONIZABLE CATIONIC LIPIDS FOR LIPID NANOPARTICLES | GENEVANT SCIENCES GMBH (CH) | 2025-10-30 | — | — | US | disclosed |
| EP-4574172-A2 | IONIZABLE CATIONIC LIPIDS FOR LIPID NANOPARTICLES | GENEVANT SCIENCES GMBH (CH) | 2025-06-25 | — | — | EP | disclosed |
| EP-4466250-B1 | IONIZABLE CATIONIC LIPIDS FOR LIPID NANOPARTICLES | GENEVANT SCIENCES GMBH (CH) | 2025-03-26 | — | — | EP | disclosed |
| EP-4466250-A1 | IONIZABLE CATIONIC LIPIDS FOR LIPID NANOPARTICLES | GENEVANT SCIENCES GMBH (CH) | 2024-11-27 | — | — | EP | disclosed |
| CN-118922401-A | Ionizable cationic lipids for lipid nanoparticles | 盖纳万科学有限公司 | 2024-11-08 | — | — | CN | disclosed |
| WO-2023144798-A1 | IONIZABLE CATIONIC LIPIDS FOR LIPID NANOPARTICLES | GENEVANT SCIENCES GMBH (CH) | 2023-08-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250332112-A1 | IONIZABLE CATIONIC LIPIDS FOR LIPID NANOPARTICLES | CETP, NPC1L1, ABCB4 | TSHR 2640/4885ALDH1A1 3387/4885USP2 3954/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.